MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

Journal of Clinical Investigation

Volumn 116, Issue 6, 2006, Pages 1494-1505

  Kanda, Hajime ^a   Tateya, Sanshiro ^a   Tamori, Yoshikazu ^a   Kotani, Ko ^a,d   Hiasa, Ken Ichi ^b   Kitazawa, Riko ^a   Kitazawa, Sohei ^a   Miyachi, Hitoshi ^c   Maeda, Sakan ^a   Egashira, Kensuke ^b   Kasuga, Masato ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^d KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC OBESITY; FATTY LIVER; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID DIET; MACROPHAGE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; WILD TYPE;

3T3 CELLS; ADIPOSE TISSUE; ANIMALS; CHEMOKINE CCL2; DIETARY FATS; FATTY LIVER; GLUCOSE; HUMANS; INSULIN RESISTANCE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; MICE, TRANSGENIC; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; TRIGLYCERIDES;

EID: 33745216724     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI26498     Document Type: Article

References (46)

1. Spiegelman, B.M., and Flier, J.S. 2001. Obesity and the regulation of energy balance. Cell. 104:531-543.
2. Kahn, B.B., and Flier, J.S. 2001. Obesity and insulin resistance. J. Clin. Invest. 106:473-481.
3. Ahima, R.S., and Flier, J.S. 2000. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 11:327-332.
4. Yoshimura, T., et al. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169:1449-1459.
5. Matsushima, K., Larsen, C.G., DuBois, G.C., and Oppenheim, J.J. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1485-1490.
6. Rollins, B.J. 1997. Chemokines. Blood. 90:909-928.
7. Yla-Herttuala, S., et al. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 88:5252-5256.
8. Takeya, M., Yoshimura, T., Leonard, E.J., and Takahashi, K. 1993. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum. Pathol. 24:534-539.
9. Gu, L., et al. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:275-281.
10. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:894-897.
11. Sartipy, P., and Loskutoff, D.J. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 100:7265-7270.
12. Hotamisligil, G.S., Shargill, N.S., and Spiegelman, B.M. 1993. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 259:87-91.
13. Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L., and Spiegelman, B.M. 1995. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95:2409-2415.
14. Fried, S.K., Bunkin, D.A., and Greenberg, A.S. 1998. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 83:847-850.
15. Weisberg, S.P., et al. 2003. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112:1796-1808. doi:10.1172/JCI200319246.
16. Xu, A., et al. 2003. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112:1821-1830. doi:10.1172/JCI200319451.
17. Abel, E.D., et al. 2001. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature. 409:729-733.
18. Yang, Q., et al. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 436:356-362.
19. Fasshauer, M., et al . 2004. Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 317:598-604.
20. Takahashi, K., et al. 2003. Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J. Biol. Chem. 278:46654-46660.
21. Coe, N.R., Simpson, M.A., and Bernlohr, D.A. 1999. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J. Lipid Res. 40:967-972.
22. Ross, S.R., et al. 1990. A fat-specific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc. Natl. Acad. Sci. U. S. A. 87:9590-9594.
23. Zhang, Y.J., Rutledge, B.J., and Rollins, B.J. 1994. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J. Biol. Chem. 269:15918-15924.
24. Zhang, Y., and Rollins, B.J. 1995. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol. Cell. Biol. 15:4851-4855.
25. Ni, W., et al. 2001. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation. 103:2096-2101.
26. Egashira, K., et al. 2002. Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ. Res. 90:1167-1172.
27. Makowski, L., et al. 2001. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 7:699-705.
28. Weisberg, S.P., et al. 2006. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J. Clin. Invest. 116:115-124. doi:10.1172/JCI24335.
29. Gong, X., et al. 1997. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors. J. Biol. Chem. 272:11682-11685.
30. Combadiere, C., et al. 1995. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J. Biol. Chem. 270:29671-29675.
31. Garcia-Zepeda, E.A., et al. 1996. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. J. Immunol. 157:5613-5626.
32. Charo, I. F., et al. 1994. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl. Acad. Sci. U. S. A. 91:2752-2756.
33. Schweickart, V.L., Epp, A., Raport, C.J., and Gray, P.W. 2000. CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines. J. Biol. Chem. 275:9550-9556.
34. Lu, D., et al. 2005. Cloning and functional characterization of the rabbit C-C chemokine receptor 2. BMC Immunol. 6:15.
35. Yamamoto, T., et al. 2004. SREBP-1 interacts with hepatocyte nuclear factor-4 alpha and interferes with PGC-1 recruitment to suppress hepatic gluconeogenic genes. J. Biol. Chem. 279:12027-12035.
36. Lewis, G.F., Carpentier, A., Adeli, K., and Giacca, A. 2002. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr. Rev. 23:201-229.
37. Christiansen, T., Richelsen, B., and Bruun, J.M. 2005. Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int. J. Obes. Relat. Metab. Disord. 29:146-150.
38. Simeoni, E., et al. 2004. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia. 47:1574-1580.
39. Bruun, J.M., Lihn, A.S., Pedersen, S.B., and Richelsen, B. 2005. Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT. J. Clin. Endocrinol. Metab. 90:2282-2289.
40. Mohanty, P., et al. 2004. Evidence for a potent antiinflammatory effect of rosiglitazone. J. Clin. Endocrinol. Metab. 89:2728-2735.
41. Chinetti, G., et al. 1998. Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages. J. Biol. Chem. 273:25573-25580.
42. Curat, C.A., et al. 2004. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes. 53:1285-1292.
43. Kim, J.K., et al. 2001. Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J. Clin. Invest. 108:153-160. doi:10.1172/JCI200110294.
44. Burant, C.F., et al. 1997. Troglitazone action is independent of adipose tissue. J. Clin. Invest. 100:2900-2908.
45. Tamori, Y., Masugi, J., Nishino, N., and Kasuga, M. 2002. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes. Diabetes. 51:2045-2055.
46. Nakamura, K., and Handa, S. 1984. Coomassie brilliant blue staining of lipids on thin-layer plates. Anal. Biochem. 142:406-410.